Brooke Bell

Brooke Bell is the Director of Trial Capabilities at Eli Lilly and Company, where they have held several leadership roles since 2021, including COO Late Phase Immunology and COO/ECG Medical Operations Advisor. Prior to joining Eli Lilly, Brooke served as a paralegal at Johnson, Smith, Pence, Densborn, Wright and Heath and was a legal manager at Allied Adjustment and Collection Co. They hold a Bachelor's degree in Legal Administration and Criminal Justice from Ball State University, obtained in 1995.